Uterine sarcomas: Clinical and histopathological aspects. Report on 15 cases;Sarcomes utérins : aspects cliniques et histopathologiques. À propos de 15 cas

Gynecologie Obstetrique et Fertilite

Volumn 36, Issue 6, 2008, Pages 628-635

  Leung, F ^a   Terzibachian, J J ^a   Aouar, Z ^a   Govyadovskiy, A ^a   Lassabe, C ^a  

^a Centre Hospitalier de Belfort   (France)

Author keywords

Histopathological diversity; Retrospective diagnosis; Uterine sarcomas

Indexed keywords

ADENOSARCOMA; ADULT; AGED; ARTICLE; BRACHYTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CARCINOSARCOMA; CLINICAL ARTICLE; ECHOGRAPHY; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HYSTERECTOMY; LEIOMYOSARCOMA; PELVIS LYMPHADENECTOMY; PHYSICAL EXAMINATION; RETROSPECTIVE STUDY; RHABDOMYOSARCOMA; SALPINGOOOPHORECTOMY; TREATMENT OUTCOME; UTERUS CANCER; UTERUS SARCOMA; VAGINA BLEEDING; ADJUVANT CHEMOTHERAPY; ADJUVANT THERAPY; METHODOLOGY; MIDDLE AGED; MORTALITY; OVARIECTOMY; PATHOLOGY; PROGNOSIS; SARCOMA; SURVIVAL RATE; TIME;

AGED; AGED, 80 AND OVER; CHEMOTHERAPY, ADJUVANT; FEMALE; HUMANS; HYSTERECTOMY; MIDDLE AGED; NEOPLASM STAGING; OVARIECTOMY; PROGNOSIS; RADIOTHERAPY, ADJUVANT; RETROSPECTIVE STUDIES; SARCOMA; SURVIVAL RATE; TIME FACTORS; TREATMENT OUTCOME; UTERINE NEOPLASMS;

EID: 48749083326     PISSN: 12979589     EISSN: 17696682     Source Type: Journal    
DOI: 10.1016/j.gyobfe.2008.03.012     Document Type: Article

References (51)

1. Salazar O.M., Bonfiglio T.A., and Patten S.F. Uterine sarcomas: natural history, treatment and prognosis. Cancer 42 (1978) 1152-1160
2. Disaia P.J., and Creasman W.T. Sarcoma of the uterus. Clin Gynecol Oncol (1989) 198-213
3. Olah K.S., Dunn J.A., and Gee H. Retrospective analysis of 318 cases of uterine sarcoma. Eur J Cancer 27 (1991) 1095-1099
4. Jereczek B., Jassem J., and Kobierska A. Sarcoma of the uterus, a clinical study of 42 patients. Arch Gynecol Obstet 258 (1996) 171-180
5. Gonzalez-Bosquet E., Martinez-Palones, and Gonzalez-Bosquet J. Uterine sarcoma: a clinico-pathological study of 93 patients. Eur J Gynaecol Oncol 3 (1997) 192-195
6. Marchese M.J., and Liskon A.S. Uterine sarcomas: a clinicopathologic study 1965-1981. Gynecol Oncol 18 (1984) 299-312
7. Archaya S., Hensley M.L., and Montag A. Rare uterine cancers. Lancet 6 (2005) 961-971
8. Livi L., Paiar F., and Shah N. Uterine sarcoma: twenty-seven years of experience. Int J Radiat Oncol Biol Phys 57 5 (2003) 1366-1373
9. Tinkler S.D., and Cowie V.J. Uterine sarcomas: a review of the Edinburgh experience from 1974 to 1992. Br J Radiol 66 (1993) 998-1001
10. Moskovic E., MacSweeney E., and Law M. Survival, patterns of spread and prognostic factors in uterine sarcoma: a study of 76 patients. Br J Radiol 66 (1993) 1009-1015
11. Nordal R.R., and Thoresen S.O. Uterine sarcomas in norway 1956-1992: incidence, survival and mortality. Eur J Cancer 33 (1997) 907-911
12. Nickie-Psikuta M., and Gawrychowski K. Different types and different prognosis-study of 310 uterine sarcomas. Eur J Gynaecol Oncol 14 suppl (1993) 105-113
13. Denschlag D., Masoud I., and Stanimir G. Prognostic factors and outcome in women with uterine sarcoma. EJSO 33 (2007) 91-95
14. Pautier P., Genestie C., and Rey A. Analysis of clinicopathologic prognostic factors for 157 uterine sarcomas and evaluation of a grading score validated for soft tissue sarcoma. Cancer 88 (2000) 1425-1431
15. Goerge M., Pejovic M.H., and Kramar A. Gynecologic cooperating group of French oncology centers: uterine sarcomas; prognostic factors and treatment modalities-study on 209 patients. Gynecol Oncol 24 (1986) 58-67
16. Wheelock J.B., Krebs H.B., and Schneider V. Uterine sarcoma: analysis of prognostic variables in 71 cases. Am J obstet Gynecol 151 (1985) 1016-1022
17. Livi L., Andreapoulou E., and Shah N. Treatment of uterine sarcoma at the Royal Marsden Hospital from 1974 to 1998. Clin Oncol 16 (2004) 261-268
18. Benoit L., Arnould L., and Cheynel N. The role of surgery and treatment trends in uterine sarcoma. EJSO 31 (2005) 434-442
19. Morice P., Rodrigues A., and Pautier P. Chirurgie des sarcomes utérins : revue de la littérature et recommandations sur la prise en charge chirurgicale. Gynecol Obstet Fertil 31 (2003) 147-150
20. Chauveinc L., Deniaud E., and Plancher C. Uterine sarcomas: the curie institut experience. Prognosis factors and adjuvant treatments. Gynecol Oncol 72 (1999) 232-237
21. Scully RE, Bonfiglio TA, Kurman RJ. Histological typing of female genital tract tumours. In World Health Organization international histological classification of tumours; second edition, springer-verlag 1994: 14-18.
22. Oliva E., Clement P.B., and Young R.H. Mesenchymal tumours of the uterus: selected topics emphasizing diagnostic pitfalls. Curr Diagn Pathol 8 (2002) 268-282
23. King M.E., and Kramer E.E. Malignant mullerian tumours of the uterus. A study of 21 cases. Cancer 45 (1980) 188-190
24. McCluggage M.G. Uterine carcinosarcomas (malignant mixed mullerian tumors) are metaplastic carcinomas. Int J Gynecol Cancer 12 (2002) 687-690
25. McCluggage W.G. Malignant biphasic uterine tumours: carcinosarcomas or metaplastic carcinomas?. J Clin Pathol 55 (2002) 321-325
26. Amant F., Moerman P., and Cadron I. The diagnostic problem of endometrial stromal sarcoma: report on six cases. Gynecol Oncol 99 (2003) 37-43
27. Amant F., Moerman P., and Vergote I. The classification of a uterine sarcoma as "high- grade endometrial stromal sarcoma" should be abandoned. Gynecol Oncol 95 (2004) 412-418
28. Schaepman-Van E.J. Mixed tumors and carcinosarcomas of the uterus evaluated five years after treatment. Cancer 25 (1970) 72-77
29. Cohen I. Endometrial pathologies associated with postmenopausal tamoxifen treatment. Gynecol Oncol 94 (2004) 256-266
30. Bouchardy C., Verkoojen H.M., and Fioretta. Increased risk of malignant mullerian tumors of the uterus among women with breast cancer treated by tamoxifen. J Clin Oncol 20 (2002) 4403
31. Wickerham D.L., Fisher B., and Wolmark N. Association of tamoxifen and uterine sarcoma. J Clin Oncol 20 (2002) 2758-2760
32. Ismail S.M. Pathology of endometrium treated with tamoxifen. J Clin Pathol 47 (1994) 827-843
33. Mc Cluggage W.G., Abdulkader M., and Price J.H. Uterine carcino-sarcoma in patients receiving tamoxifen: areport of 19 cases. Int J Gynecol Cancer 10 (2000) 280-284
34. Barter J., Smith E., and Szpak C. Leiomyosarcoma of the uterus: clinicopathologic study of 21 cases. Gynecol Oncol 21 (1985) 220-227
35. Schwartz L., diamond M., and Schwartz P. Leiomyosarcomas: clinical presentation. Am J Obstet Gynecol 168 (1993) 180-183
36. Parker W.H., Yao S.F., and Jonathan S.B. Uterine sarcoma in patients operated on for presumed leiomyoma and rapidly growing leiomyoma. Obstet Gynecol 83 (1994) 414-418
37. Schwartz L.B., Zaroin M., and Concanglu M.L. Does pelvic magnetic resonance imaging differentiate among the histologic subtypes of uterine leiomyomata?. Fertil Steril 70 3 (1998) 580-587
38. Sahdev A., Sohaib S.A., and Jacobs I. MR imaging of uterine sarcomas. Am J Roentgenol 177 6 (2001) 1307-1311
39. Riopel J., Plante M., and Renaud M.C. Lymph node metastases in low-grade endometrial stromal sarcoma. Gynecol Oncol 96 (2005) 402-406
40. Disaia P.J., Morrow C.P., and Boronow R. Endometrial sarcomas: lymphatic spread pattern. Am J Obstet Gynecol 130 (1978) 104-105
41. Chen S. Propensity of retroperitoneal lymph node metastasis in patients with stage I sarcoma of the uterus. Gynecol Oncol 32 (1989) 215-217
42. Goff B.A., Rice L.W., and Fleischhacker D. Uterine leiomyosarcoma and endometrial stromal sarcoma: lymph node metastases and sites of recurrence. Gynecol Oncol 50 (1993) 105-109
43. Podczaski E.S., Woomert C.A., and Stevens C.W. Management of malignant mixed mesodermal tumours of the uterus. Gynecol Oncol 32 (1989) 240-244
44. Salazar O.M., Bonfiglo T.A., and Patten S.F. Uterine sarcomas: analysis of failures with special emphasis on the use of adjuvant radiation therapy. Cancer 42 (1978) 1161-1171
45. Reed N.S., Mangioni C., and Malmstrom H. First results of a randomised trial comparing radiotherapy versus observation post operatively in patients with uterine sarcomas. An EORTC-GCG study. Int J Gynecol Cancer 13 Suppl 1 (2003) 4
46. Knocke T.H., Kucera H., and Dörfler D. Results of postoperative radiotherapy in the treatment of sarcoma of the corpus uteri. Cancer 83 (1998) 1972-1979
47. Deniaud-Alexandre E., Chauveinc L., and de la Rochefordière A. Intérêt des traitements adjuvants dans les sarcomes utérins : expérience de l'institut curie. Cancer Radiother 6 (2001) 743-749
48. Omura G.A., Blessing J.A., and Major F. A randomized clinical trial of adjuvant adriamycin in uterine sarcoma. A gynecologic Oncology Group study. J Clin Oncol 3 (1985) 1240-1245
49. Pautier P. Sarcomes utérins. Oncologie 9 (2007) 137-143
50. Gadducci A., Cosio S., and Romanini A. The management of uterine sarcoma: a debated clinical challenge. Crit Rev Oncol Hematol 65 2 (2007) 129-142
51. Norris H.J., and Taylor H.B. Mesenchymal tumors of the uterus. A clinical and pathological study of 53 endometrial stromal tumors. Cancer 19 (1966) 755-766